LABCORP HOLDINGS INC. (LH)
About LABCORP HOLDINGS INC.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
American Credentials
Each credential is independently reviewed before it’s awarded · last reviewed Jun 9, 2026. How this is verified →
Financial summary
- Revenue FY2025
- $14.0B
- Net income
- $876.5M
- Total assets
- $18.4B
- Market cap
- $21.7B
- Gross margin
- 28.8%
- Operating margin
- 9.9%
- Net margin
- 6.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $14.0B
- Cost of revenue
- $9.9B
- Gross profit
- $4.0B
- Operating expenses
- $2.6B
- Operating income
- $1.4B
- Income tax
- $229.8M
- Net income
- $877.7M
- EPS (basic)
- $10.54
- EPS (diluted)
- $10.46
Balance sheet
- Total assets
- $18.4B
- Current assets
- $4.0B
- Total liabilities
- $9.8B
- Current liabilities
- $2.8B
- Shareholders’ equity
- $8.6B
Cash flow
- Operating cash flow
- $1.6B
- Investing cash flow
- -$1.2B
- Financing cash flow
- -$1.5B
- Net cash flow
- -$986.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $21.7B
- P/E ratio
- 28.4
- EPS (diluted)
- $10.46
- Dividend yield
- 0.97%
- Shares outstanding
- 73.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 7, 1988
Labcorp Holdings Inc. (LH) Stock Price
- Profitable — net income of $876.5M in FY2025.
- Revenue declined 13% from FY2021 to FY2025.
- Gross margin of 28.8%, net margin 6.3%.
- Trading near its 52-week high.
- Pays a dividend yielding about 0.97% annually.
- Valued at a price-to-earnings (P/E) ratio of 28.4.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review LABCORP HOLDINGS INC..
Write a review
News about LABCORP HOLDINGS INC.
News & sentiment via Polygon.io
Labcorp Holdings Inc.: frequently asked questions
Is Labcorp Holdings Inc. an American company?
Yes — Labcorp Holdings Inc. is an American company headquartered in Burlington, North Carolina. Its American-origin credentials have been independently reviewed and verified by americancompanies.com.
Where is Labcorp Holdings Inc. headquartered?
Labcorp Holdings Inc. is headquartered in Burlington, North Carolina, United States.
Is Labcorp Holdings Inc. publicly traded?
Yes — Labcorp Holdings Inc. is a publicly traded company. Its stock trades under the ticker symbol LH on the NYSE.
What does Labcorp Holdings Inc. do?
Labcorp Holdings Inc. is an American Medical Devices company in the Health & Beauty sector.
